Risk Factors for Recurrent Fibrovascular Proliferation in Aggressive Posterior Retinopathy of Prematurity After Early Vitreous Surgery

American Journal of Ophthalmology

Volumn 150, Issue 1, 2010, Pages

  Yokoi, Tadashi ^a   Yokoi, Tae ^a   Kobayashi, Yuri ^a   Nishina, Sachiko ^a   Azuma, Noriyuki ^a  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRESSIVE POSTERIOR RETINOPATHY OF PREMATURITY; APGAR SCORE; ARTICLE; BIRTH WEIGHT; BLEEDING; CASE STUDY; CLINICAL ARTICLE; EYE SURGERY; FEMALE; FIBROVASCULAR TISSUE; GESTATIONAL AGE; HUMAN; HYDROCEPHALUS; INTUBATION; LASER COAGULATION; MALE; MULTIVARIATE ANALYSIS; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN SURGERY; OBSERVATIONAL STUDY; PATENT DUCTUS ARTERIOSUS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA DETACHMENT; RETINA NEOVASCULARIZATION; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; SURGICAL RISK; TISSUE GROWTH; UNIVARIATE ANALYSIS; VASCULAR TISSUE; VITRECTOMY; VITREOUS BODY;

EID: 77953880999     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2010.02.005     Document Type: Article

References (30)

1. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 123 (2005) 991-999
2. Early Treatment for Retinopathy of Prematurity Cooperative G. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 121 (2003) 1684-1694
3. Chong L.P., Machemer R., and de Juan E. Vitrectomy for advanced stages of retinopathy of prematurity. Am J Ophthalmol 102 (1986) 710-716
4. Trese M.T., and Droste P.J. Long-term postoperative results of a consecutive series of stages 4 and 5 retinopathy of prematurity. Ophthalmology 105 (1998) 992-927
5. Greven C., and Tasman W. Scleral buckling in stages 4B and 5 retinopathy of prematurity. Ophthalmology 97 (1990) 817-820
6. Hinz B.J., de Juan Jr. E., and Repka M.X. Scleral buckling surgery for active stage 4A retinopathy of prematurity. Ophthalmology 105 (1998) 1827-1830
7. Noorily S.W., Small K., de Juan Jr. E., and Machemer R. Scleral buckling surgery for stage 4B retinopathy of prematurity. Ophthalmology 99 (1992) 263-268
8. Trese M.T. Scleral buckling for retinopathy of prematurity. Ophthalmology 101 (1994) 23-26
9. Azuma N., Ishikawa K., Hama Y., et al. Early vitreous surgery for aggressive posterior retinopathy of prematurity. Am J Ophthalmol 142 (2006) 636-643
10. Moshfeghi A.A., Banach M.J., Salam G.A., et al. Lens-sparing vitrectomy for progressive tractional retinal detachments associated with stage 4A retinopathy of prematurity. Arch Ophthalmol 122 (2004) 1816-1818
11. Lakhanpal R.R., Sun R.L., Albini T.A., et al. Anatomic success rate after 3-port lens-sparing vitrectomy in stage 4A or 4B retinopathy of prematurity. Ophthalmology 112 (2005) 1569-1573
12. Fortes Filho J.B., Eckert G.U., Procianoy L., et al. Incidence and risk factors for retinopathy of prematurity in very low and in extremely low birth weight infants in a unit-based approach in southern Brazil. Eye 23 (2009) 25-30
13. Karkhaneh R., Mousavi S.Z., Riazi-Esfahani M., et al. Incidence and risk factors of retinopathy of prematurity in a tertiary eye hospital in Tehran. Br J Ophthalmol 92 (2008) 1446-1449
14. Shah V.A., Yeo C.L., Ling Y.L., and Ho L.Y. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann Acad Med Singapore 34 (2005) 169-178
15. O'Keefe M., Burke J., Algawi K., and Goggin M. Diode laser photocoagulation to the vascular retina for progressively advancing retinopathy of prematurity. Br J Ophthalmol 79 (1995) 1012-1014
16. Schulenburg W.E., and Tsanaktsidis G. Variations in the morphology of retinopathy of prematurity in extremely low birthweight infants. Br J Ophthalmol 88 (2004) 1500-1503
17. Hartnett M.E. Pediatric retina: medical and surgical approaches (2005), Lippincott Williams & Wilkins, Philadelphia 559 xv
18. Hikichi T., Nomiyama G., Ikeda H., and Yoshida A. Vitreous changes after treatment of retinopathy of prematurity. Jpn J Ophthalmol 43 (1999) 543-545
19. Flynn J.T., Cassady J., Essner D., et al. Fluorescein angiography in retrolental fibroplasia: experience from 1969-1977. Ophthalmology 86 (1979) 1700-1723
20. Yokoi T. Vascular abnormalities in aggressive posterior retinopathy of prematurity detected by fluorescein angiography. Ophthalmology 116 (2009) 1377-1382
21. Funatsu H., Yamashita H., Noma H., et al. Outcome of vitreous surgery and the balance between vascular endothelial growth factor and endostatin. Invest Ophthalmol Vis Sci 44 (2003) 1042-1047
22. Young T.L., Anthony D.C., Pierce E., et al. Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity. J AAPOS 1 (1997) 105-110
23. Nishina S., Yokoi T., Yokoi T., et al. Effect of early vitreous surgery for aggressive posterior retinopathy of prematurity detected by fundus fluorescein angiography. Ophthalmology 116 (2009) 2442-2447
24. Vinekar A., Trese M.T., and Capone Jr. A. Evolution of retinal detachment in posterior retinopathy of prematurity: impact on treatment approach. Am J Ophthalmol 145 (2008) 548-555
25. Travassos A., Teixeira S., Ferreira P., et al. Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity. Ophthalmic Surg Lasers Imaging 38 (2007) 233-237
26. Kusaka S., Shima C., Wada K., et al. Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study. Br J Ophthalmol 92 (2008) 1450-1455
27. Mintz-Hittner H.A., and Kuffel Jr. R.R. Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina 28 (2008) 831-838
28. Honda S., Hirabayashi H., Tsukahara Y., and Negi A. Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 246 (2008) 1061-1063
29. Kita T., Hata Y., Arita R., et al. Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target. Proc Natl Acad Sci U S A 105 (2008) 17504-17509
30. Gondorfer A. Pharmacologic vitreolysis. Dev Ophthalmol 39 (2007) 149-156